Prognosis
J&J Says Covid-19 Booster Shot Triggered an Antibody Surge
- Early data show a second injection led to a ninefold increase
- Company to discuss booster time frame with health officials
This article is for subscribers only.
Johnson & Johnson said a booster of its Covid-19 vaccine provided a rapid and strong increase in antibodies, supporting use of a second shot among people who previously received its single-dose immunization.
A second dose of the J&J vaccine led to a ninefold increase in Covid-fighting antibodies compared with the levels participants had 28 days after getting their first shot, the health-care giant said Wednesday, citing interim data from an early-stage trial.